1. Home
  2. APGE vs ALKT Comparison

APGE vs ALKT Comparison

Compare APGE & ALKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • ALKT
  • Stock Information
  • Founded
  • APGE 2022
  • ALKT 2007
  • Country
  • APGE United States
  • ALKT United States
  • Employees
  • APGE N/A
  • ALKT N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • ALKT EDP Services
  • Sector
  • APGE Health Care
  • ALKT Technology
  • Exchange
  • APGE Nasdaq
  • ALKT Nasdaq
  • Market Cap
  • APGE 3.0B
  • ALKT 3.1B
  • IPO Year
  • APGE 2023
  • ALKT 2021
  • Fundamental
  • Price
  • APGE $47.25
  • ALKT $35.93
  • Analyst Decision
  • APGE Strong Buy
  • ALKT Buy
  • Analyst Count
  • APGE 5
  • ALKT 9
  • Target Price
  • APGE $75.20
  • ALKT $38.00
  • AVG Volume (30 Days)
  • APGE 366.5K
  • ALKT 1.1M
  • Earning Date
  • APGE 11-12-2024
  • ALKT 10-30-2024
  • Dividend Yield
  • APGE N/A
  • ALKT N/A
  • EPS Growth
  • APGE N/A
  • ALKT N/A
  • EPS
  • APGE N/A
  • ALKT N/A
  • Revenue
  • APGE N/A
  • ALKT $315,562,000.00
  • Revenue This Year
  • APGE N/A
  • ALKT $28.58
  • Revenue Next Year
  • APGE N/A
  • ALKT $24.11
  • P/E Ratio
  • APGE N/A
  • ALKT N/A
  • Revenue Growth
  • APGE N/A
  • ALKT 26.73
  • 52 Week Low
  • APGE $16.39
  • ALKT $21.19
  • 52 Week High
  • APGE $72.29
  • ALKT $41.36
  • Technical
  • Relative Strength Index (RSI)
  • APGE 35.00
  • ALKT 46.95
  • Support Level
  • APGE $57.85
  • ALKT $37.24
  • Resistance Level
  • APGE $63.50
  • ALKT $38.49
  • Average True Range (ATR)
  • APGE 3.86
  • ALKT 1.61
  • MACD
  • APGE -0.90
  • ALKT -0.39
  • Stochastic Oscillator
  • APGE 4.97
  • ALKT 25.62

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.

About ALKT Alkami Technology Inc.

Alkami Technology Inc is a cloud-based digital banking solutions provider. Alkami Platform, allows FIs to onboard and engage new users, accelerate revenues and meaningfully improve operational efficiency with the support of a proprietary, true cloud-based, multi-tenant architecture.

Share on Social Networks: